Tag: Chemotherapy-Induced Neutropenia Treatment Market

The chemotherapy-induced neutropenia treatment market is witnessing significant growth due to the rising prevalence of cancer and the increasing adoption of chemotherapy as a standard treatment modality. Chemotherapy-induced neutropenia is a common side effect of chemotherapy, characterized by an abnormally low count of neutrophils, a type of white blood cell crucial for fighting infections. This condition poses…